{
    "code": "01030626",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01030626",
    "time": "2020-02-25 05:26:09",
    "許可證字號": "衛署藥製字第030626號",
    "註銷狀態": "已註銷",
    "註銷日期": "98\/04\/01",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "99\/02\/03",
    "發證日期": "77\/02\/03",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103062600",
    "中文品名": "泰胃美注射液200公絲\/2公撮（希美替定）",
    "英文品名": "TAGAMET R INJECTION 200MG\/2ML (CIMETIDINE)",
    "適應症": "住院病人伴隨有病理性胃酸分泌過高之症狀，頑固性（難治的）十二指腸潰瘍或不能口服之病人消化性潰瘍之短期替代療法",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CIMETIDINE",
    "限制項目": "01國　產",
    "申請商名稱": "0402606200  中國化學製藥股份有限公司新豐工廠",
    "申請商地址": "新竹縣新豐鄉坑子口１８２之１號",
    "主製造廠": [
        {
            "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
            "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640000500",
            "成分名稱": "CIMETIDINE",
            "含量描述": "200",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ]
}